U.S. Overdose Deaths Fell About 14% In 2025, CDC Preliminary Data Show
CDC preliminary data released Wednesday, May 13, 2026 estimate about 70,000 U.S. overdose deaths in 2025 — about 14% fewer than in 2024.[1]
The totals mark the third straight annual decline, the longest such drop in decades, and bring deaths roughly back to 2019 pre-pandemic levels.[2] Declines were reported across multiple drug classes, including fentanyl, cocaine and methamphetamine, though seven states recorded increases, with jumps of 10% or more in Arizona, Colorado and New Mexico.[1] Officials and researchers warned the pace of decline slowed in 2025, reducing confidence that the trend will continue without sustained action.[2]
U.S. overdose deaths peaked at nearly 110,000 in 2022, a surge researchers linked to pandemic-era isolation and disrupted addiction care.[2] Public-health analysts attribute part of the recent fall to wider naloxone availability, expanded addiction treatment, opioid settlement funding, fewer high-risk users and a shrinking supply of fentanyl precursor chemicals from China.[1] A federally funded toxicology lab in Horsham, Pennsylvania identified 27 newly detected drugs in the illicit supply in 2025 and had flagged 23 more by early May 2026.[1] Analysts singled out cychlorphine, a synthetic opioid described as many times stronger than fentanyl, which has appeared as a cutting agent in seized products.[2]
Experts cautioned that the slowdown in the 2025 decline, the rapid emergence of potent new synthetics and possible policy changes could reverse recent gains without continued investment in prevention, treatment and monitoring.[1]
Show source details & analysis (3 sources)
📌 Key Facts
- CDC preliminary data released Wednesday, May 13, 2026 estimate about 70,000 U.S. overdose deaths in 2025 — about 14% fewer than in 2024 (CDC preliminary data).
- The 2025 total represents the third straight annual decline — the longest such drop in decades — bringing deaths roughly back to 2019 pre‑pandemic levels, though the pace of decline slowed in 2025 (third straight annual decline).
- Declines were seen across multiple drug classes (including fentanyl, cocaine and methamphetamine), but seven states had increases, with rises of 10% or more in Arizona, Colorado and New Mexico (Arizona, Colorado and New Mexico).
- CDC data and researchers point to possible drivers of the decline such as wider naloxone availability, expanded addiction treatment, opioid settlement funding, fewer high‑risk users and reduced availability of fentanyl precursor chemicals from China (wider naloxone availability).
- A federally funded toxicology laboratory in Horsham, Pennsylvania identified 27 newly seen drugs in the illicit supply in 2025 and flagged 23 more in the first five months of 2026 (Horsham, Pennsylvania).
- Reporters and lab officials singled out cychlorphine as a newly detected, very potent synthetic opioid — described as up to 10 times stronger than fentanyl — and said it is being used as a cutting agent in illicit drugs (cychlorphine).
- Experts quoted in the reporting warn that the slowdown in the 2025 decline, plus the rapid emergence of new synthetic drugs and potential policy shifts, could reverse recent improvements (Experts).
📰 Source Timeline (3)
Follow how coverage of this story developed over time
- Article reiterates that preliminary CDC data released Wednesday, May 13, 2026, estimate about 70,000 U.S. overdose deaths in 2025, about 14% fewer than in 2024 and roughly back to 2019 levels.
- It notes that 2025 marked the third consecutive annual decline in overdose deaths, but emphasizes that the pace of decline slowed compared with prior years.
- The piece highlights that seven states saw overdose death increases in 2025, with rises of 10% or more in Arizona, Colorado and New Mexico, and suggests those may be tied to combined fentanyl–methamphetamine use patterns.
- The article underscores that U.S. overdose deaths peaked at nearly 110,000 in 2022, with researchers linking the pandemic-era spike to social isolation and disrupted addiction treatment access.
- It gives additional detail that a federally funded toxicology lab in Horsham, Pennsylvania identified 27 newly seen drugs in 2025 and has already flagged 23 more in the first five months of 2026.
- The article singles out cychlorphine as a potent synthetic opioid, described as up to 10 times stronger than fentanyl and being used as a cutting agent in illicit drugs.
- CDC preliminary data released Wednesday, May 13, 2026, estimate "about 70,000" U.S. overdose deaths in 2025 and describe that as "about 14%" fewer than 2024.
- Article states 2025 marks the third straight annual decline in overdose deaths, the longest such decline in decades, and that the 2025 toll is roughly back to 2019 pre-pandemic levels.
- Declines were seen across multiple drug classes, including fentanyl, cocaine and methamphetamine, while seven states had increases, with jumps of 10% or more in Arizona, Colorado and New Mexico.
- CDC data and quoted researchers highlight several possible drivers of the decline, including wider naloxone availability, expanded addiction treatment, opioid settlement funding, shrinking numbers of high-risk users, and reduced availability of fentanyl precursor chemicals from China.
- Toxicology monitoring in 2025 identified 27 newly detected drugs in the illicit supply and by early May 2026 had already found 23 more, including the potent synthetic opioid cychlorphine and veterinary sedatives like xylazine and medetomidine.
- Experts quoted in the article warn that the overdose decline slowed in 2025 and that rapid emergence of new synthetic drugs and potential policy changes could reverse the trend.